Receptor Glucagon
Os receptores de glucagon são GPCRs que mediam os efeitos do glucagon, um hormônio envolvido na regulação da homeostase da glicose, promovendo a quebra de glicogênio e a liberação de glicose pelo fígado. Esses receptores são críticos na gestão dos níveis de açúcar no sangue e são de particular interesse no estudo do diabetes e distúrbios metabólicos. Antagonistas dos receptores de glucagon estão sendo explorados como potenciais tratamentos para hiperglicemia no diabetes tipo 2. Na CymitQuimica, oferecemos uma variedade de moduladores de receptores de glucagon de alta qualidade para apoiar sua pesquisa em endocrinologia, diabetes e regulação metabólica.
Foram encontrados 164 produtos de "Receptor Glucagon"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Retatrutide sodium salt
<p>Retatrutide sodium salt is a glucagon receptor and glucagon-like peptide-1 receptor agonist for the study of type 2 diabetes mellitus.</p>Pureza:99.97%Cor e Forma:SoildRetatrutide
CAS:<p>Retatrutide (LY3437943) is a triple agonist of GCGR, GIPR and GLP-1R that can be used to study obesity.</p>Fórmula:C221H342N46O68Pureza:98.31%Cor e Forma:SolidPeso molecular:4732.09Glucagon (1-29), bovine, human, porcine hydrochloride
CAS:<p>Glucagon (1-29), bovine, human, porcine hydrochloride is a peptide hormone, produced by pancreatic α-cells. Glucagon increases HNF4α phosphorylation.</p>Fórmula:C153H225N43O49S·ClHPureza:95.65% - 98.03%Cor e Forma:SolidPeso molecular:3519.21Tirzepatide monosodium salt
<p>Tirzepatide sodium salt (LY3298176 sodium salt) is a GIP and GLP-1 receptor agonist with neuroprotective activity and can be used to treat obesity.</p>Fórmula:C225H347N48O68NaPureza:99.69%Cor e Forma:SoildPeso molecular:4835.51Volagidemab
CAS:<p>Anti-CD34 Antibody is a CHO-expressed humanized monoclonal antibody targeting CD34, which can be used for the study of neurological and cardiovascular diseases.</p>Pureza:97.8% (SDS-PAGE); 98% (SEC-HPLC) - 97.8% (SDS-PAGE); 98% (SEC-HPLC)Cor e Forma:LiquidPF-06882961
CAS:<p>PF-06882961 is an orally bioavailable glucagon-like peptide-1 receptor (GLP-1R) agonist.</p>Fórmula:C31H30FN5O4Pureza:98.06% - 99.54%Cor e Forma:SolidPeso molecular:555.6Avexitide acetate
CAS:<p>Avexitide acetate (exendin 9-39) is a potent glucagon-like peptide 1 receptor (GLP-1R) antagonist for the study of post-obesity hypoglycemia.</p>Fórmula:C155H246N40O53SPureza:96.64% - 98.65%Cor e Forma:SolidPeso molecular:3549.91Crotedumab
CAS:<p>Crotedumab (REGN1193) is a humanized antibody targeting GCGR, which reduces fasting blood glucose and improves glucose tolerance, used in diabetes research.</p>Pureza:>95%Cor e Forma:LiquidGLP-1 receptor agonist 8
CAS:<p>GLP-1 receptor agonist 8, potent for diabetes and obesity research, may also study NAFLD.</p>Fórmula:C34H36ClFN6O4Cor e Forma:SolidPeso molecular:647.14GLP-1(7-37)
CAS:<p>GLP-1 (7-37) is a truncated, bioactive form of GLP-1 that is the product of proglucagon processing in intestinal endocrine L cells.</p>Fórmula:C151H228N40O47Pureza:98%Cor e Forma:SolidPeso molecular:3355.67Oxyntomodulin
CAS:<p>GLP-1 analog modulates appetite, boosts metabolism, and curbs gastric acid. Increases cAMP, mildly stimulates glucagon receptor.</p>Fórmula:C192H295N59O60SPureza:98%Cor e Forma:SolidPeso molecular:4421.86HAEGTFTSD
CAS:<p>HAEGTFTSD is GLP-1's initial segment; GLP-1 (7-36) amide, tied to food intake, stems from preproglucagon in L-cells.</p>Fórmula:C40H57N11O17Pureza:98%Cor e Forma:SolidPeso molecular:963.94Exendin-3/4 (59-86)
<p>Exendin-3/4 (59-86) is a Exendin-4 peptide derivative.</p>Fórmula:NAPureza:98%Cor e Forma:SolidPeso molecular:3055.49Secretin, porcine
CAS:<p>Porcine secretin: 27-amino acid peptide for diagnosing pancreatic dysfunction and gastrinoma, stimulates bicarbonate fluid.</p>Fórmula:C130H220N44O41·xC2H4O2Pureza:98%Cor e Forma:SolidPeso molecular:N/A[Des-His1,Glu9]-Glucagon amide
CAS:<p>Glucagon blocker with pA2 of 7.2; no agonist effect. Boosts insulin; prevents glucagon-driven hyperglycemia in rabbits and diabetic rats.</p>Fórmula:C148H221N41O47SPureza:98%Cor e Forma:SolidPeso molecular:3358.68Albiglutide fragment TFA
<p>Albiglutide fragment (GLP-1 (7-36) analog) TFA represents a biologically active segment of Albiglutide, resistant to DPP-4 degradation due to its structure as a</p>Fórmula:C148H224N40O45·xC2HF3O2Cor e Forma:SolidV-0219 hydrochloride
<p>V-0219 hydrochloride: oral GLP-1R PAM for obesity-linked diabetes study.</p>Fórmula:C20H26ClF3N4O2Pureza:99.97%Cor e Forma:SoildPeso molecular:446.89GIP/GLP-1 dual receptor agonist-1
CAS:<p>Compound 4: GIP/GLP-1 agonist for metabolic/fatty liver disease research.</p>Cor e Forma:Solid(R)-V-0219 hydrochloride
<p>(R)-V-0219 hydrochloride: Oral GLP-1R PAM, enantiomer of V-0219, triggers Ca2+ flux in hGLP-1R HEK cells.</p>Fórmula:C20H26ClF3N4O2Cor e Forma:SolidPeso molecular:446.89(S, R)-LSN 3318839
CAS:<p>(S,R)-LSN 3318839 enhances GLP-1R, shows strong blood sugar lowering in animals, works with sitagliptin.</p>Fórmula:C26H23Cl2N3O2Pureza:99.57%Cor e Forma:SoildPeso molecular:480.39LSN3160440
CAS:<p>LSN3160440 is a GLP-1R allosteric modulator and PPI stabilizer aiding inactive GLP-1 attachment.</p>Fórmula:C27H27Cl2N3OCor e Forma:SolidPeso molecular:480.43VU0453379 hydrochloride
<p>VU0453379 hydrochloride: selective CNS-penetrant GLP-1R PAM, EC50 1.3 μM.</p>Fórmula:C26H35ClN4O2Cor e Forma:SolidPeso molecular:471.03GLP-1R agonist 14
CAS:<p>GLP-1R agonist 14, also known as Compound 14, is a potent agonist of the GLP-1 receptor, demonstrating an EC50 range of 0-20 nM against human GLP-1 [1].</p>Fórmula:C45H42F2N10O5Cor e Forma:SolidPeso molecular:840.88GLP-1R Antagonist 1
CAS:<p>GLP-1R Antagonist 1 is an orally active, CNS penetrant and non-competitive glucagon-like peptide 1 receptor (GLP-1R) antagonist (IC50: 650 nM).</p>Fórmula:C16H11ClF6N4O2Pureza:99.84%Cor e Forma:SolidPeso molecular:440.73GLP-1 receptor agonist 13
<p>Compound (S)-9, a GLP-1 receptor agonist, exhibits an EC50 of 76 nM for the glucagon GLP-1 receptor [1].</p>Fórmula:C25H23ClF2N6OCor e Forma:SolidPeso molecular:496.94Albiglutide Fragment
CAS:<p>Albiglutide fragment is a 30-amino-acid sequence of modified human GLP-1 (fragment 7-36).</p>Fórmula:C148H224N40O45Pureza:98%Cor e Forma:SolidPeso molecular:3283.6Tirzepatide
CAS:<p>Tirzepatide (LY-3298176) is a dual glucose-dependent polypeptide (GIP) (EC50=0.042 nM) and glucagon-like peptide-1 (GLP-1) (EC50=0.086 nM) receptor agonist.</p>Fórmula:C225H348N48O68Pureza:99.52% - 99.99%Cor e Forma:SolidPeso molecular:4813.45Cinnamtannin A2
CAS:<p>Cinnamtannin A2, a tetrameric procyanidin, boosts GLP-1, insulin, CRH expression, and has antioxidant, anti-diabetic, nephroprotective properties.</p>Fórmula:C60H50O24Cor e Forma:SolidPeso molecular:1155.02{Val1}-Exendin-3/4
<p>{Val1}- exendin-3/4 is the first n-terminal 1-28 residue of exendin-4 peptide.</p>Fórmula:NAPureza:98%Cor e Forma:SolidPeso molecular:3241.7Tirzepatide hydrochloride
<p>Tirzepatide HCl is a dual GIP and GLP-1 receptor agonist.</p>Fórmula:C225H349N48O68ClPureza:98%Cor e Forma:SolidPeso molecular:4849.91GLP-1R agonist 29
<p>GLP-1R agonist 29 (Compound 20) is a GLP-1R agonist that induces hGLP-1R-mediated cAMP stimulation with an EC50 of 0.018 nM. It exhibits favorable pharmacokinetic properties and shows good in vivo exposure, with an AUC0-∞,sc of 77688 ng·h/mL.</p>Cor e Forma:Odour SolidGLP-1R agonist 27
<p>GLP-1R agonist 27 (compound 21) is a potent and orally active GLP-1R agonist. It enhances the accumulation of cyclic adenosine monophosphate (cAMP), reduces blood glucose levels, and decreases food intake. GLP-1R agonist 27 shows potential for research in obesity and type 2 diabetes mellitus (T2DM).</p>Fórmula:C32H33N5O4SeCor e Forma:SolidPeso molecular:630.6GLP-1 receptor agonist 4
CAS:<p>GLP-1 receptor agonist 4 targets GLP-1R, EC50 64.5 nM, potential diabetes treatment research.</p>Fórmula:C51H44Cl2N4O6Pureza:98%Cor e Forma:SolidPeso molecular:879.82VU0453379
CAS:<p>VU0453379 is a highly selective and central nervous system penetrant positive allosteric modulator of glucagon-like peptide-1R (EC50: 1.3 μM).</p>Fórmula:C26H34N4O2Pureza:98%Cor e Forma:SolidPeso molecular:434.57Glucagon (19-29), human
CAS:<p>Glucagon, a 29-amino-acid hormone, is produced by alpha cells in the pancreas' islets of Langerhans.</p>Fórmula:C61H89N15O18SPureza:98%Cor e Forma:SolidPeso molecular:1352.53GLP-1 (9-36) amide
CAS:<p>GLP-1 (9-36) amide is an antagonist at the human GLP-1 receptor.</p>Fórmula:C140H214N36O43Pureza:97%Cor e Forma:SolidPeso molecular:3089.41TT-OAD2 free base
CAS:<p>TT-OAD2 free base, a non-peptide GLP-1 receptor agonist, can treat diabetes; has an EC50 of 5 nM.</p>Fórmula:C50H47Cl2N3O6Pureza:98%Cor e Forma:SolidPeso molecular:856.83Glucagon-like peptide 1 (1-37), human
CAS:<p>Human GLP-1 (1-37) is a potent GLP-1 receptor agonist without impact on rat food intake or insulin secretion.</p>Fórmula:C186H275N51O59Pureza:98%Cor e Forma:SolidPeso molecular:4169.48Secretin (28-54), human
CAS:<p>Secretin (28-54), human, is a 27-amino acid residue peptide with a C-terminal amidation, acting on human secretin receptors.</p>Fórmula:C130H220N44O40Pureza:98%Cor e Forma:PowderPeso molecular:3039.46Albenatide
CAS:<p>Albenatide is a modified analog of exendin 4 conjugated to recombinant human albumin.</p>Fórmula:C26H47N7O9SPureza:98%Cor e Forma:SolidPeso molecular:633.76HAEGTFTSDVS
CAS:<p>HAEGTFTSDVS is the first N-terminal 1-11 residues of GLP-1 peptide.</p>Fórmula:C48H71N13O20Pureza:98%Cor e Forma:SolidPeso molecular:1150.18Pal-Glu(OSu)-OH
CAS:<p>Pal-Glu(OSu)-OH is a Liraglutide side chain, a GLP-1 agonist for type 2 diabetes study.</p>Fórmula:C25H42N2O7Cor e Forma:SolidPeso molecular:482.618TT-OAD2
CAS:<p>TT-OAD2 is a non-peptide agonist of glucagon-like peptide-1 (GLP-1) receptor (EC50: 5 nM), with the potential for diabetes treatment.</p>Fórmula:C50H49Cl4N3O6Pureza:98%Cor e Forma:SolidPeso molecular:929.75GLP-2(1-33)(human)
CAS:<p>GLP-2(1-33) (human) is an enteroendocrine hormone which stimulates the growth of the intestinal epithelium.</p>Fórmula:C165H254N44O55SPureza:98%Cor e Forma:SolidPeso molecular:3766.19HAEGTFT
CAS:<p>HAEGTFT is the first N-terminal 1-7 residues of GLP-1 peptide.</p>Fórmula:C33H47N9O12Pureza:98%Cor e Forma:SolidPeso molecular:761.78Taspoglutide
CAS:<p>Taspoglutide is a long-acting glucagon-like peptide 1 (GLP-1) receptor agonist(EC50 value of 0.06 nM),and for treatment of type 2 diabetes</p>Fórmula:C152H232N40O45Pureza:98%Cor e Forma:SolidPeso molecular:3339.763GLP-1 moiety from Dulaglutide
<p>GLP-1 moiety from Dulaglutide is a 31-amino acid fragment of Dulaglutide which is a glucagon-like peptide 1 receptor (GLP-1) agonist.</p>Fórmula:C149H221N37O49Pureza:98%Cor e Forma:SolidPeso molecular:3314.62Apraglutide
CAS:<p>Apraglutide (FE 203799 is a synthetic 33-amino acid peptide and long-acting glp-2 analogue.</p>Fórmula:C172H263N43O52Pureza:98%Cor e Forma:SolidPeso molecular:3765.25Dulaglutide
CAS:<p>Dulaglutide (LY2189265) is a GLP-1 receptor agonist for studying type 2 diabetes mellitus (T2DM).</p>Cor e Forma:SolidGlucagon receptor antagonists-1
CAS:<p>Glucagon receptor antagonist -1 is a highly effective glucagon receptor antagonist.</p>Fórmula:C29H34FNO2Pureza:98%Cor e Forma:SolidPeso molecular:447.58
![[Des-His1,Glu9]-Glucagon amide](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTM%2Fthumb-webp%2FTP2033.webp&w=3840&q=75)
